Granules eyes foray into peptide segment, CDMO business with ₹192 cr. acquisition of ...
Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation (CDMO) business with a ₹192.5 crore (CHF 20 million) acquisition of Swiss ...
JSE-listed Altvest shares drop 9% following historic bitcoin investment
JSE-listed investment firm Altvest Capital sees shares plummet 9. 23% following its inaugural R1. 81 million Bitcoin purchase ...